Liu Haohan, Yan Yongcong, Lin Jianhong, He Chuanchao, Liao Hao, Li Huoming, Zhou Zhenyu, Wang Jie, Mao Kai, Xiao Zhiyu
Department of Hepatobiliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.
Mol Ther Nucleic Acids. 2022 Aug 15;29:788-802. doi: 10.1016/j.omtn.2022.08.008. eCollection 2022 Sep 13.
Hepatitis B virus X protein (HBx) is considered as an oncogene in tumorigenesis and progression of hepatocellular carcinoma (HCC). In recent years, the important role of circular RNAs (circRNAs) in HCC has been increasingly demonstrated. However, the regulatory mechanisms of HBx on circRNAs remains largely unknown. In this study, we identified that a novel circRNA, circSFMBT2, was markedly downregulated by HBx. Low expression of circSFMBT2 was correlated with poor prognosis and vascular invasion. Functionally, overexpression of circSFMBT2 significantly inhibited HCC metastasis both and . The mechanism of circSFMBT2 was to as a sponge of miR-665, which is a negative regulator of tissue inhibitor of metalloproteinases 3 (TIMP3). However, HBx downregulated circSFMBT2 via the interaction with DExH-box helicase 9 (DHX9), which binds to flanking circRNA-forming introns. In conclusion, circSFMBT2, which is downregulated by HBx, acts as a tumor suppressor to inhibit tumor metastasis through the miR-665/TIMP3 axis. Our study suggests that circSFMBT2 could be a potential prognostic biomarker and therapeutic target for HCC.
乙型肝炎病毒X蛋白(HBx)在肝细胞癌(HCC)的肿瘤发生和进展过程中被视为一种癌基因。近年来,环状RNA(circRNAs)在HCC中的重要作用得到了越来越多的证实。然而,HBx对circRNAs的调控机制在很大程度上仍不清楚。在本研究中,我们鉴定出一种新型环状RNA,即circSFMBT2,其表达被HBx显著下调。circSFMBT2的低表达与预后不良和血管侵犯相关。在功能上,circSFMBT2的过表达在体内和体外均显著抑制HCC转移。circSFMBT2的作用机制是作为miR-665的海绵,而miR-665是金属蛋白酶组织抑制剂3(TIMP3)的负调节因子。然而,HBx通过与DExH盒解旋酶9(DHX9)相互作用下调circSFMBT2,DHX9与侧翼形成circRNA的内含子结合。总之,被HBx下调的circSFMBT2作为一种肿瘤抑制因子,通过miR-665/TIMP3轴抑制肿瘤转移。我们的研究表明,circSFMBT2可能是HCC潜在的预后生物标志物和治疗靶点。